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Summary The effects of progressive cachexia on protein metabolism in skeletal muscle has been investigated
in mice bearing the MAC16 adenocarcinoma which produces cachexia with tumour burdens of <1% of the
host weight. Weight loss was accompanied by loss of whole body nitrogen in proportion to the overall loss of
body mass. Using L-[4-3H]phenylalanine to label proteins in gastrocnemious muscle, a significant depression
(60%) in protein synthesis occurred in animals with a weight loss between 15 and 30% accompanied by an
increase in protein degradation, which increased with increasing weight loss between 15 and 30%. Muscle
degradation in vitro could be achieved by serum from cachectic animals, which appeared to contain a
proteolysis-inducing factor. These results suggest that the increased degradation of skeletal muscle seen in this
model of cachexia may be due to a circulating proteolysis-inducing factor.
Cancer cachexia is a syndrome of progressive of weight loss,
with erosion of host body tissues, in particular adipose tissue
and muscle in response to tumour growth. Depletion of
visceral protein and lean body mass (as assessed by serum
albumin and creatinine:height index) have a worse prognostic
impact than depletion of adipose tissue, and the greater the
weight loss the poorer the prognosis and the lower the res-
ponse rate to chemotherapy (De Wys, 1986).
Skeletal muscle mass declines during the progression of
cachexia and white or phasic muscle tends to atrophy more
rapidly than red or tonic muscle (Clark & Goodlad, 1971).
Peripheral muscle wasting may be due to increased muscle
catabolism or decreased protein synthesis or a combination
of the two. The relative importance of synthesis and degrada-
tion vary between individual studies. Thus Emery et al.
(1984) have suggested that muscle mass in cancer cachexia is
regulated primarily by alterations in the protein synthetic
rate, while changes in protein degradation are largely secon-
dary. Also decreased muscle protein synthesis as measured by
the incorporation of ['4C]leucine into muscle protein has been
observed in human rectus abdominis muscle from cancer
patients when compared with age-matched controls (Lund-
holm et al., 1976). In contrast, the exceptionally high protein
turnover rates in some patients with hepatocellular car-
cinoma were found to be a consequence of elevated
endogenous protein breakdown and oxidation of amino acids
(O'Keefe et al., 1990). Also in animals bearing the Yoshida
AH-130 hepatoma (Tessitore et al., 1987) depletion of muscle
protein was shown to arise from an elevation in the rate of
protein degradation with no apparent change in protein syn-
thesis. Other studies in tumour-bearing animals have shown
that loss of muscle protein occurs by both a decrease in
protein synthesis and an elevation in muscle protein break-
down (Norton et al., 1981). Our own studies on cancer
cachexia have concentrated on a murine model (MAC16
colon adenocarcinoma). Weight loss in this model occurs
without a decrease in calorie intake and is associated with a
reduction in muscle dry weight in direct proportion to the
tumour burden (Beck & Tisdale, 1987). The present study
investigates changes in whole body nitrogen content with the
development of cachexia and the relative contributions of
protein synthesis and degradation to the nitrogen balance in
skeletal muscle.
Materials and methods
Animals
Pure strain female NMRI mice were obtained from our own
breeding colony and were fed a rat and mouse breeding diet
(Pilsbury Ltd., Birmingham, UK) and water ad libitum.
Animals (average body weight 20 g) were transplanted with
fragments of the MAC16 tumour into the flank by means of
a trocar as described (Bibby et al., 1987) and fed ad libitum.
Weight loss started to occur 10 to 12 days after transplanta-
tion when the tumours became palpable and animals were
used with varying degrees of weight loss up to a maximum of
25 to 30% as agreed by the Coordinating Committee on
Cancer Research of the United Kingdom for the welfare of
animals with neoplasms. For studies on protein synthesis and
degradation animals were killed by cervical dislocation and
their gastrocnemius muscles were quickly ligated, dissected
out and placed in ice-cold isotonic saline. The muscles were
then blotted, weighed and carefully tied via tendon ligatures
(Wu & Thompson, 1988) to stainless steel incubation sup-
ports to prevent contraction, thus improving protein balance
and energy status (Baracos & Goldberg, 1986). For deter-
mination of total carcass fat and water content, each carcass
was placed in an oven at 80'C until constant weight was
reached. Carcasses were then reweighed, and the total fat
content was determined by the method of Lundholm et al.
(1976). Water content was calculated from the wet and dry
weights. Total body nitrogen was assessed by the micro-
kjeldahl method. For this determination the whole mouse
carcass was homogenised in 0.9% NaCl, freeze dried and
ground with a pestle and mortar to achieve a homogeneous
mixture. The gastrocnemius muscle and liver were analysed
separately.
Blood was removed from animals under anaesthesia
between 9.30 and 10.30 a.m. and allowed to clot for 10min
at room temperature. Serum was obtained by centrifugation
at 1,300 r.p.m. for 5 min and stored at - 70'C until required.
In the experiments depicted in Figures 5 and 6 the serum
constituted 7% of the assay volume.
Determination ofprotein synthesis
Both protein synthesis and degradation in isolated gastro-
cnemius muscles were determined essentially according to the
method of Wu and Thompson (1988). All animals were
sacrificed between 9-10 a.m. to minimise diurnal variation
and were assumed to be in the fed state. Muscles were
preincubated in Dulbecco's minimal essential medium
(DMEM) (3 ml) saturated with 02:C02 (19:1) for 30 min at
37TC. After rinsing in nonradioactive medium, fresh medium
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containing 50 p Ci of L-[4-3H] phenylalanine (specific activity,
46.3 mCi mmol-') (Amersham International, Amersham,
UK) was added and the muscles were incubated for a further
2 h with continuous gassing. At the end of the final incuba-
tion period the muscles were rinsed in nonradioactive
medium, blotted, and homogenised in 3 ml 2% HC104. The
homogenate was centrifuged at 2,800g for 15 min and the
supernatant was added to saturated tripotassium citrate
(1.5 ml) to give a pH close to 6.0. The insoluble potassium
perchlorate was removed by centrifugation and the radio-
activity in the supernatant was determined after dilution (1:1)
to given the intracellular free pool of L-[4-3H]]phenylalanine.
The precipitate from the original centrifugation was
washed three times with 5 ml 2% HC104 and hydrolysed in
5 ml 6 N HCl at 10°C in sealed glass tubes for 24 h. The
hydrolysates were evaporated to dryness and the residue was
dissolved in 10 ml distilled water. A 1 ml sample of the
solution was added to 10 ml Optiphase Hi-safe 3 scintillation
fluid (FSA Laboratory Supplies, Loughborough, UK) for
determination of the protein bound radioactivity. The rate of
protein synthesis was calculated by dividing the amount of
protein bound radioactivity by the amount of acid soluble
radioactivity.
Measurement ofprotein degradation
Female NMRI mice from the same group used to measure
protein synthesis were injected i.p. with 0.25 ml of isotonic
saline containing 150g Ci of L-[4-3H]phenylalanine (sp. act.
1.5 Ci mmol-'). At 24 h after isotope injection the animals
were killed by cervical dislocation and the gastrocnemius
muscle was isolated and pre-incubated as above. After rins-
ing, the muscles were incubated in DMEM (3 ml) for 2 h
with continuous gassing and the muscle and media were
treated as above. The rate of protein degradation was cal-
culated by dividing the amount of L-[4-3H]phenylalanine
released into the incubation media during the final 2 h
incubation period by the specific radioactivity of protein
bound radioactivity.
In the experiment depicted in Figure 5 protein degradation
was determined by tyrosine release. The conditions were
similar to the above except that the supernatant was used for
the measurement of tyrosine by a fluorimetric method
(Waalkes & Undenfriend, 1957) at 570 nm on a Perkin-Elmer
LS-5 luminescence spectrometer.
Results
The effect ofprogressive weight loss on the body composition
of female NMRI mice bearing the MAC16 tumour is shown
in Figure 1. As weight loss progresses the size of the individ-
ual compartments decreases, although apart from the fat
content of the carcass, the relative contribution of each re-
mains the same (Table I). Thus cachexia in this model is
associated with a disproportionate decrease in adipose mass
with loss of muscle proportional to the overall decrease in
body weight.
The conservation of nitrogen during progressive weight
loss is illustrated by the relative constancy of the nitrogen
content of the carcass excluding the tumour, as measured by
the microkjeldahl method (Figure 2). Only at a weight loss
between 16 and 25% was a significant decrease in whole
body nitrogen observed. However, the nitrogen content of
individual organs did decrease as weight loss increased. Thus
there is a significant nitrogen loss in gastrocnemius muscle
between 11 and 30% weight loss (Figure 3a) paralleling the
decrease in muscle wet weight (Table II). There is also a
significant decrease in the nitrogen content of the liver above
11% weight loss (Figure 3b), while the nitrogen content of
the tumour (Figure 3c) increases proportionally with tumour
growth and this increase is maintained and even enhanced
throughout the progression of cachexia. Thus changes in
homeostasis leading to nitrogen depletion from host organs
do not apply to the tumour.
Depletion of skeletal muscle mass may arise from a
decrease in protein synthesis and/or an increase in protein
degradation. Both synthesis and degradation were measured
in isolated gastrocnemius muscle using L-[4-3H]phenylalanine
to label proteins. The results presented in Figure 4 show the
in vitro protein synthesis and degradation using this techni-
que in gastrocnemius muscle from animals with increasing
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Figure 1 The effect ofprogressive cachexia on body composition of female NMRI mice. Animals weighing 20 g were transplanted
with fragments of the MAC16 tumour and the body composition was determined at intervals. Each bar represents the mean of four
mice.
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Figure 2 Effect of progressive weight loss in mice bearing the MAC16 tumour in total body nitrogen content. Each bar represents
the mean ± s.e.m. for four animals. Differences were determined by one-way analysis of variance as **P<0.01 compared to
non-tumour-bearing animals.
degrees of weight loss. Muscle protein synthesis is
significantly depressed in animals with a weight loss of
between 16 and 20% and remains at a low level up to a
weight loss of 30%. This is accompanied by an increased
protein degradation, which increases with weight loss
between 15 and 30% up to a maximum 240% increase at a
weight loss of 30%. Protein degradation also appears to be
increased at lower weight loss (5-15%) but is not
significantly different from animals without weight loss pos-
sibly because n is not large enough. We have previously
attributed wasting of skeletal muscle in animals bearing the
MAC16 tumour to a circulating proteolytic factor not found
in animals bearing tumours which do not induce cachexia
(Beck & Tisdale, 1987). Using an in vitro assay to measure
muscle degradation in gastrocnemius muscle, the level of a
protein degradative factor in serum from animals bearing the
MAC16 tumour can be shown to increase with increasing
weight loss up to 20% and thereafter decreases to levels not
Table I Effect ofprogressive cachexia on the relative contributions of
fat, water and non-fat mass to the total body compositiona
Weight loss 00) Fat (%) Water (%O) Non-fat mass (
0 12.6 ± 1.4 64.6 ± 2.0 22.9 ± 0.6
1 5 10.0±0.9 66.5±0.8 23.5±0.3
6-10 10.8 0.7 65.5 0.7 23.7 0.5
11-15 7.5±1.1 66.0±1.5 26.4±0.4
16-20 6.7 ± 0.7 66.6 ± 1.3 26.7 ± 1.6
21 -25 6.7 0.8 65.2 2.1 28.2 2.1
26-30 4.1 1.5 67.3 1.3 28.6 1.3
aResults are expressed as mean ± s.e.m. for four mice per group.
Table 11 Effect of progressive cachexia on the wet weight of
gastrocnemius muscle in female NMRI mice bearing the MAC16
adenocarcinoma
Weight loss (00) Muscle wneight (mg) ( s.e.m.)
0 139±2
0 5 132±3
5- 10 129 3
11 -15 126 4a
16-20 117 7a
21 -25 107 2b
26-30 106 3b
ap< 0.05 from animals without weight loss by one-way ANOVAR.
bP<0.01 from animals without weight loss by one-way ANOVAR.
significantly different from that found in animals without
weight loss (Figure 5). This suggests that this material may
initiate protein degradation in skeletal muscle, but may not
be responsible for protein degradation at high weight loss.
Serum from mice bearing the MAC16 adenocarcinoma and
with weight loss between 16 and 20% caused a decrease in
protein synthesis in isolated gastrocnemius muscle from
4.34 ± 0.41 to 2.87 ± 0.45 nmol mg 2 h (P<0.05) using L-[4-
3H]phenylalanine (Figure 6). The effect did not arise from a
decrease in precursor incorporation caused by increased
levels of phenylalanine in the serum of cachectic animals,
since we have previously reported no change in the concent-
ration of phenylalanine in the serum of NMRI mice with the
development of cachexia (Beck & Tisdale, 1989).
Discussion
As body weight declines with the progression of cachexia in
animals bearing the MAC16 tumour, the relative contribu-
tion of nitrogen to the total carcass mass decreases in pro-
portion to the decrease in body weight of the animals. Both
gastrocnemius muscle and liver nitrogen decrease with
increasing weight loss, while the total tumour nitrogen in-
creases. Some studies have suggested that tumours can func-
tion as nitrogen traps, competing with the host for nitrogen
compounds (Carrascosa et al., 1984). Certainly the average
nitrogen content of the tumour at 26% weight loss is approx-
imately 17 mg which would coincide with the loss of 7 mg of
nitrogen from the liver and 10 mg from muscle mass (1 mg
from gastrocnemius muscle which represents approximately
10% of the muscle mass in the animal). This raises the
possibility of direct competition between host and tumour for
available nitrogen but does not explain why other tumours in
this series e.g. MAC13 can grow without the loss of body
nitrogen content.
Previous studies (Beck & Tisdale, 1989) have shown an
elevation in nitrogen excretion in animals bearing the
MAC16 tumour at low weight loss, followed by a conserva-
tion mechanism such that the excretion level fell to or below
that found in non tumour bearing animals at higher weight
loss. This nitrogen excretion profile parallels the observed
changes in carcass nitrogen content with the progression of
cachexia in this model.
We have shown that loss of nitrogen from gastrocnemius
muscle is associated with a decrease in protein synthesis
combined with a large increase in protein degradation as the
weight loss increases. The decrease in protein synthesis occurs
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Figure 3 Effect of progressive weight loss in mice bearing the MAC16 tumour on total nitrogen content of gastrocnemius muscle
a, total liver nitrogen content b, and total tumour nitrogen content c. Each bar represents the mean ± s.e.m. for four animals.
Differences were determined by one-way analysis of variance as *P<0.05 and **P<0.01 compared to non-tumour bearing
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Figure 4 Effect of progressive cachexia on protein synthesis (solid box) and degradation (stippled box) in gastrocnemius muscle of
mice bearing the MAC16 tumour. Results are expressed as mean + s.e.m. for six animals per group. Differences were determined by
one-way analysis of variance as **P<0.O from non tumour-bearing animals. Protein degradation in animals with 26 30% weight
loss is significantly different (P<0.05) from animals with 16-20% weight loss.
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Figure 5 Effect of serum from mice bearing the MAC16 tumour and with progressive weight loss on tyrosine release from
gastrocnemius muscle. Serum (280 IlI) was added to freshly isolated gastrocnemius muscle isolated from non tumour-bearing
animals and the tyrosine released during a 2 h incubation was determined as described in methods. Differences were determined by
one-way analysis of variance as *P<0.05 and **P<0.01 from animals with no weight loss.
in the absence of a drop in food intake and all measurements
have assumed animals to be in the fed state. Studies in cancer
patients suggest the importance of the timing of the study
with regards to the fed or fasting state. Thus Emery et al.
(1984) found a decrease in protein synthesis in cachectic
patients in the fed state, while Shaw et al. (1991) demon-
strated an increase in protein synthesis after an overnight
fast.
The effect on both protein synthesis and degradation in
isolated gastrocnemius muscle can be produced by serum
from cachectic animals. This suggests that the systemic effect
of the tumour on the host is mediated by circulatory factors,
and we have previously provided evidence for a proteolysis-
inducing factor in the serum of cachectic mice bearing the
MAC16 tumour (Beck & Tisdale, 1987). Similar material has
also been detected in the plasma of cancer patients with
weight loss greater than 10% (Belizario et al., 1991). The
nature of this material is not known, although some studies
have suggested that the cytokines tumour necrosis factor
alpha (TNF-a) (Flores et al., 1989), alone or in combination
with interleukin-1 (Hellerstein et al., 1989) increase muscle
proteolysis possibly through a prostaglandin intermediate.
We have recently shown (Mulligan et al., 1992) that TNF-a
is not involved in the induction of cachexia in animals bear-
ing the MAC16 tumour, although Belizario et al. (1991) have
shown that the human proteolysis-inducing factor was par-
tially abrogated with antibodies to recombinant IL-I in 10%
of their patients. It seems likely that the induction of protein
catabolism in cancer cachexia may be mediated by a com-
bination of cytokines, the classical protein metabolism
regulatory hormones, catecholamines, glucagon and gluco-
corticoids or other unidentified factors. One interesting
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potential candidate for this role is the polyunsaturated fatty
acid arachidonic acid. Arachidonate has been shown to both
inhibit protein synthesis (Rotman et al., 1992) and increase
protein degradation in skeletal muscle (Rodeman & Gold-
berg, 1982), the latter by the mediation of a prostaglandin E2
(PGE2) intermediate. Treatment of rats with the cyclooxy-
genase inhibitor naproxen inhibited muscle protein loss pro-
duced by the Yoshida ascites hepatoma (Strelkov et al.,
1989). Thus the possibility arises that the products of fat
mobilisation from the adipose tissue may be responsible for
increased protein turnover in skeletal muscle.
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Figure 6 Effect of serum from non tumour-bearing mice (solid
box) and from mice bearing the MAC16 tumour and with weight
loss 16-30% (hatched box) on gastrocnemius muscle protein
synthesis. Serum (280 1l) was added to freshly isolated gastro-
cnemius muscle preparations and muscle protein synthesis was
determined by the incorporation of L-[4_3H] phenylalanine as
described in Methods. Differences were determined by Student's
t-test as *P<0.05 from non tumour-bearing controls.
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